
### [DOID:8692](http://purl.obolibrary.org/obo/DOID_8692)
**Label:** myeloid leukemia

**Subclasses:** [DOID:9119](http://purl.obolibrary.org/obo/DOID_9119) (acute myeloid leukemia), [DOID:8864](http://purl.obolibrary.org/obo/DOID_8864) (acute monocytic leukemia), [DOID:8552](http://purl.obolibrary.org/obo/DOID_8552) (chronic myeloid leukemia), 

**Corr. equiv. classes:** [OMIM:151380](http://purl.obolibrary.org/obo/OMIM_151380), [OMIM:601626](http://purl.obolibrary.org/obo/OMIM_601626), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), 

**Class expressions from DL-Learner:**

- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0004845](http://purl.obolibrary.org/obo/HP_0004845) (Acute monocytic leukemia) 66.67%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0002488](http://purl.obolibrary.org/obo/HP_0002488) (Acute leukemia) 66.67%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and (not ([HP:0005558](http://purl.obolibrary.org/obo/HP_0005558) (Chronic leukemia))) 66.67%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and (not ([HP:0005550](http://purl.obolibrary.org/obo/HP_0005550) (Chronic lymphatic leukemia))) 66.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 55.10%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 54.23%
- Thing 54.21%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 54.21%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) 52.02%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 52.02%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 52.02%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 52.02%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 52.02%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 52.02%
- [HP:0001444](http://purl.obolibrary.org/obo/HP_0001444) (Autosomal dominant somatic cell mutation) and [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 52.02%


